Related Experiment Video
Updated: May 22, 2026
A Murine Model of Irreversible and Reversible Unilateral Ureteric Obstruction
Published on: December 20, 2014
Is BMP-7 a promising diagnostic and prognostic biomarker for pediatric obstructive uropathy?
Mehdi Shirazi1,2, Seyed Hossein Hosseini3, Maryam Salehi1
1Department of Urology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Insights
Bone morphogenetic protein-7 (BMP-7) showed limited diagnostic and prognostic value in pediatric obstructive uropathy. Further research is needed to explore its role in predicting kidney recovery and fibrosis.
Area of Science:
- Pediatric Nephrology
- Biomarker Discovery
- Renal Injury
Background:
- Obstructive uropathy is a key cause of pediatric chronic kidney disease.
- Biomarkers to predict disease progression or recovery are needed.
- Bone morphogenetic protein-7 (BMP-7) has shown renoprotective effects in models.
Purpose of the Study:
- To assess serum and urinary BMP-7 levels in pediatric obstructive uropathy.
- To evaluate the diagnostic and prognostic significance of BMP-7.
Main Methods:
- Prospective observational study of 200 pediatric patients with obstructive uropathy and 200 controls.
- Measured serum and urinary BMP-7 pre- and post-surgery using ELISA.
- Statistical analyses compared groups and pre/postoperative measurements.
Main Results:
- No statistically significant differences in serum or urinary BMP-7 between patients and controls.
- No significant changes in BMP-7 levels post-surgery.
- No significant variations observed among different obstruction subtypes.
Conclusions:
- BMP-7 has limited clinical utility for diagnosing or predicting outcomes in pediatric obstructive uropathy.
- Future studies should investigate additional biomarkers and longer follow-up periods.
- BMP-7's potential in predicting renal recovery and fibrosis modulation requires further research.
Background:
Obstructive uropathy remains a major contributor to pediatric chronic kidney disease. Reliable biomarkers that predict disease progression or recovery are still lacking. Bone morphogenetic protein-7 (BMP-7), known for its anti-fibrotic and renoprotective properties, has been proposed as a promising biomarker in renal injury. This study aimed to assess serum and urinary BMP-7 levels in pediatric obstructive uropathy and to evaluate its potential diagnostic and prognostic significance.
Methods:
This prospective observational study enrolled 200 pediatric patients with obstructive uropathy (including UPJO, UVJO, and PUV) and 200 healthy controls. Serum and urinary BMP-7 levels were measured before and three months after surgery using a human BMP-7 ELISA kit (Zellbio). Comparisons were made between groups and between pre- and postoperative measurements using appropriate statistical analyses.
Results:
Urinary BMP-7 levels were marginally higher and serum BMP-7 levels slightly lower in patients than in controls; however, these differences were not statistically significant (P > 0.05). Postoperative evaluations revealed a minor decrease in urinary BMP-7 and a mild increase in serum BMP-7, but again without statistical significance. No significant variations were found among obstruction subtypes (UPJO, UVJO, PUV).
Conclusion:
While BMP-7 plays a recognized role in renal repair in experimental models, its clinical diagnostic and prognostic utility in pediatric obstructive uropathy appears limited. Future research incorporating additional biomarkers and longer follow-up may further elucidate BMP-7's potential in predicting renal recovery and fibrosis modulation.